Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study / Diener, H.c., Sacco, R., Yusuf, S., Blank, B., Cotton, D., Gu, V., Hermansson, K., Hilbrich, L., Humphreys, M., Lawton, W.a., Machnig, T., Ounpuu, S., Vandermaelen, C., Voigt, T., Wu, Y., Albers, G., Bath, P., Bornstein, N., Chan, B., Chen, S.t., et al.. - In: LANCET NEUROLOGY. - ISSN 1474-4422. - STAMPA. - 7:10(2008), pp. 875-884. [10.1016/S1474-4422(08)70198-4]

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

PROVINCIALI, LEANDRO;
2008-01-01

2008
Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Cognition; Dipyridamole; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; International Cooperation; Male; Mental Status Schedule; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Severity of Illness Index; Stroke; Ticlopidine; Neurology (clinical)
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/237680
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 111
  • Scopus 320
  • ???jsp.display-item.citation.isi??? 262
social impact